Image

axSEND: Exploring Immune and Microbiota Effects of a Partial Enteral Nutrition Diet in Axial Spondyloarthritis

axSEND: Exploring Immune and Microbiota Effects of a Partial Enteral Nutrition Diet in Axial Spondyloarthritis

Recruiting
16 years and older
All
Phase N/A

Powered by AI

Overview

People with axial spondyloarthritis (axSpA) often have intestinal inflammation and intestinal microbiome dysbiosis, with some similarities to Crohn's-like inflammatory bowel disease (IBD) gut inflammation. However, research has not addressed whether Partial Enteral Nutrition (PEN), a diet formed of a liquid formula and some solid whole foods, which is effective at inducing remission in IBD, may influence the dysbiotic microbiome and inflamed, hyperpermeable intestine of axSpA patients, and whether these changes may be accompanied by alterations in systemic markers of inflammation. Thus, there is a need to determine the effects of PEN on these aspects in axSpA patients.

In this study, the investigators intend to trial a 2-week course (with optional additional 2-week extension) of a PEN diet in people with active axSpA disease. A group of healthy volunteers following the same diet will act as a control.

Eligibility

Eligibility Criteria for Participants with axSpA

Inclusion criteria. Participants will fulfil ALL of the following:

  • Diagnosis of axSpA (fulfilling the ASAS criteria)
  • Active disease (BASDAI score ≥4) on day of study visit
  • Stable on treatment [defined as (1) no major change to therapy (change in treatment type) in the preceding 3 months AND (2) no minor change in therapy (adjustment of treatment dosage) in the preceding 1 month]
  • Age ≥ 16 years
  • Willing and able to give informed written consent.

Exclusion. Participants will have NONE of the following:

  • Pregnancy or breastfeeding
  • Prior diagnosis of IBD
  • Recipient of chemotherapy/immunotherapy/radiotherapy in prior 3 months
  • Recent systemic antibiotic use (within last 1 month)
  • Current eating disorder
  • Food allergy incompatible with diet (e.g. cow's milk allergy)
  • Following a vegan diet
  • Major surgery in prior 3 months or planned in forthcoming 3 months.
  • Unable or unwilling to give informed consent
  • Unable or unwilling to try the PEN diet.

Eligibility Criteria for Healthy Volunteer Participants

Inclusion criteria. Participants will fulfil ALL of the following:

  • Age ≥ 16 years
  • Current student and/or staff member at the University of Glasgow
  • Willing and able to give informed written consent

Exclusion. Participants will have NONE of the following:

  • Pregnancy or breastfeeding
  • Prior diagnosis of an immune-mediated inflammatory condition
  • Recipient of chemotherapy/immunotherapy/radiotherapy in prior 3 months
  • Recent systemic antibiotic use (within last 1 month)
  • Current eating disorder
  • Food allergy incompatible with diet (e.g. cow's milk allergy)
  • Following a vegan diet
  • Major surgery in prior 3 months or planned in forthcoming 3 months.
  • Unable or unwilling to give informed consent
  • Unable or unwilling to try the PEN diet.

Study details
    Axial Spondyloarthritis
    Ankylosing Spondylitis
    Inflammation
    Dysbiosis
    Arthritis
    Spondylitis
    Spondylarthritis
    SpA
    AxSpA

NCT06460805

NHS Greater Glasgow and Clyde

25 June 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.